What type of study is this?

This is a In Vitro Study study.

September 5, 2025Open Access

Supplementary Figure S5 from RORγt Inhibition Reduces Protumor Inflammation and Decreases Tumor Growth in Experimental Models of Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Experimental models show that RORγt inhibition decreases tumor growth in lung cancer, suggesting inflammation regulation may be key.

RORγt inhibition significantly reduces tumor growth in experimental models of lung cancer, indicating a therapeutic potential.
Findings reveal that Rorg expression is not affected by IL-1R1 signaling in lung cancer cells, highlighting a specific regulatory mechanism.
Methodology involved in vitro assessment of Rorg expression related to IL-1R1 signaling in lung cancer models, clarifying its role.
These insights may support the development of therapeutic strategies targeting protumor inflammation in lung cancer.

Yamada‐Hara et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark